Current position:Home >Product >
2,6-Di-O-butyryl-myo-inositol 1,3,4,5-tetrakisphosphate-octakis(propionoxymethyl) ester
2,6-Di-O-butyryl-myo-inositol 1,3,4,5-tetrakisphosphate-octakis(propionoxymethyl) ester(503158-20-1)
- Name: 2,6-Di-O-butyryl-myo-inositol 1,3,4,5-tetrakisphosphate-octakis(propionoxymethyl) ester
- Synonyms:BT2-INS (1,3,4,5)P4/PM;BT2-INS (1,3,5,6)P4/PM;2,4-DI-O-BUTYRYL-MYO-INOSITOL 1,3,5,6-TETRAKISPHOSPHATE-OCTAKIS(PROPIONOXYMETHYL) ESTER;D-myo-Inositol, 1,3,4,5-tetrakis[bis[(1-oxopropoxy)methyl] phosphate] 2,6-dibutanoate (9CI);2,6-Di-O-butyryl-myo-inositol 1,3,4,5-tetrakisphosphate-octakis(propionoxymethyl) ester
- Molecular Formula:C46H76O36P4
- Molecular Weight:1328.97
- CAS Registry Number:503158-20-1
- EINECS:
- Melting Point:1028.7±65.0 °C(Predicted)
- Water Solubility:
Other Product
- 503045-74-7/1H-Indazole-6-carbonitrile, 3-(1H-indol-2-yl)-
- 50307-37-4/1-Hydroxy-7-methoxyoctamethyltetrasiloxane
- 50-30-8/N-Cyclo Hexyl P-Toluene Sulphonamide
- 503105-88-2/2-(4-(5-ethylfuran-2-yl)-6-(2,2,6,6-tetramethylpiperidin-4-ylamino)pyridin-2-yl)-4-methylphenol
- 503-10-6/2-(Difluoro)oxirane 95%
- 50310-70-8/2-[(4-methyl-1,3-thiazol-2-yl)methyl]pyridine dihydrochloride
- 503125-60-8/2-Propenamide, 3-(2,4-dimethoxyphenyl)-N-methyl-N-(1-methyl-4-piperidinyl)-
- 503125-69-7/2-Propenamide, 3-(3,5-dimethoxyphenyl)-N-methyl-N-(1-methyl-4-piperidinyl)-
- 503125-72-2/2-Propenamide, 3-(2,3-dimethoxyphenyl)-N-methyl-N-(1-methyl-4-piperidinyl)-
- 503131-11-1/2(1H)-Naphthalenone, 3,4-dihydro-1-(4-methoxyphenyl)-
- 503139-68-2/1-[2-(cyclohexen-1-yl)ethyl]-3-(3-methoxyphenyl)thiourea
- 503147-99-7/8-Methoxy-4-(trifluoromethyl)quinolin-2(1H)-one
- 503148-84-3/4-(3,5-dimethyl-1H-pyrazol-1-yl)piperidine
- 503149-66-4/2-methyl-1-piperidin-4-yl-5-(trifluoromethyl)benzimidazole
- 503155-14-4/2,7-Naphthalenedisulfonic acid, 4-amino-6-[2-[5-[[4-chloro-6-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]diazenyl]-5-hydroxy-3-[2-[2-sulfo-4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-, sodium salt (1:6)
- 503155-18-8/2,7-Naphthalenedisulfonic acid, 5-[[4-chloro-6-[ethyl[3-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[2-(1-sulfo-2-naphthalenyl)diazenyl]-, sodium salt (1:4)
- 503155-49-5/Tetrasodium 7-amino-4-hydroxy-3-[(2-methoxy-5-methyl-4-{[2-(sulfonatooxy)ethyl]sulfonyl}phenyl)diazenyl]-8-[(2-sulfonato-4-{[2-(sulfonatooxy)ethyl]sulfonyl}phenyl)diazenyl]naphthalene-2-sulfonate
- 503156-01-2/2,7-Naphthalenedisulfonic acid, 5-[[4-chloro-6-[[2-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-1-methylethyl]amino]-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[[1-sulfo-6-[[2-(sulfooxy)ethyl]sulfonyl]-2-naphthalenyl]azo]-, heptasodium salt
- 503157-00-4/Disodium 2,4-diamino-3-{[4-(ethenylsulfonyl)phenyl]diazenyl}-5-{[4-(ethenylsulfonyl)-2-sulfonatophenyl]diazenyl}benzenesulfonate
- 503158-20-1/2,6-Di-O-butyryl-myo-inositol 1,3,4,5-tetrakisphosphate-octakis(propionoxymethyl) ester
- 503160-33-6/4-Fluoro-2-(4-morpholinylmethyl)aniline
- 503165-93-3/1,3,4-Pyrrolidinetricarboxylic acid, 1-(1,1-dimethylethyl) 3-methyl ester, (3R,4S)-rel-
- 503166-49-2/ethyl (3R,4R)-4-aminotetrahydro-2H-pyran-3-carboxylate
- 503168-08-9/methyl 4-aminotetrahydrofuran-3-carboxylate hydrochloride
- 503173-93-1/[13C5]-Didanosine
- 503174-86-5/Zinc Dimethicone PEG-8 Succinate
- 503175-39-1/1H-Inden-1-one, 4-bromo-2-[(dimethylamino)methylene]-2,3-dihydro-
- 503175-53-9/Ethyl 4-phenyl-2-pyridin-4-ylpyrimidine-5-carboxylate
- 503176-32-7/2-Propenal, 3-(7-quinolinyl)-, (2E)-
- 503177-95-5/1,3(2H)-Pyridazinedicarboxylic acid, tetrahydro-, 1-(1,1-dimethylethyl) 3-methyl ester, (3S)-